Us2.ai
About Us2.ai
Us2.ai is a leading healthcare AI company dedicated to democratizing expert-level cardiac diagnostics through advanced artificial intelligence solutions. For physicians, their FDA-cleared platform automates the comprehensive analysis of echocardiograms, transforming raw 2D and Doppler images into complete, structured reports in minutes. This includes automated measurements, disease detection, and clinical findings for every chamber of the heart, significantly reducing the manual effort and time traditionally required for echo interpretation.
The company’s technology is designed to integrate seamlessly into clinical workflows, connecting to ultrasound devices and PACS to process echocardiograms in real-time. This full automation, unlike semi-automated tools, eliminates the need for manual frame selection or limited measurements, providing fully explainable AI outcomes with editable annotations. Us2.ai’s solutions are clinically validated and aim to improve diagnostic accuracy, enhance efficiency in clinical trials for pharmaceutical companies, and support the timely detection of often-missed or hard-to-diagnose cardiovascular conditions, ultimately improving patient outcomes and expanding access to high-quality cardiac assessment globally.
Us2.ai’s software has demonstrated a significant reduction in measurement and report creation time compared to manual methods, as published in the Journal of Echocardiography. Their platform is trusted by leading institutions worldwide and is FDA cleared, CE Marked, and SOC 2 Type II certified, ensuring reliability and compliance in various healthcare settings.
Focus Areas
Business Intelligence
| Key Investors | IHH Healthcare, Heal Partners, Sequoia Capital (now Peak XV Partners), EDBI, Pappas Capital, SGInnovate, Partech Ventures, Bfa Global Investors, East Post Road Ventures, FJ Labs |
| Partnerships | AstraZeneca (research), Janssen (research), Duke University, Fujifilm (OEM integration), deepc, Harrison.ai, Merative Merge, Brigham and Women's Hospital (validation study), Lenus Health, Alnylam, Viz.ai |
| Technology | Cloud-native, deep learning, AI-powered echocardiography analysis, fully automated, integrates with ultrasound devices and PACS, delivers structured reports, real-time processing, explainable AI output |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Us2.ai stands out for physicians by dramatically reducing the time spent on echocardiogram analysis and reporting (up to a 70% reduction), allowing more focus on patient interaction and complex cases. Its 100% AI automation delivers consistent, accurate, and guideline-directed reports with explainable AI outputs and editable annotations, boosting diagnostic confidence and reproducibility across studies and institutions. The platform's ability to detect often under-diagnosed conditions like cardiac amyloidosis from a single view, combined with comprehensive measurements and disease indications, supports earlier and more precise treatment decisions. Furthermore, its vendor-neutral and seamless integration capabilities streamline workflow, address sonographer shortages, and enable scalability for higher patient volumes without compromising quality.
Us2.ai is designed for seamless integration into existing clinical workflows. It connects directly to standard ultrasound devices via Us2.connect and is compatible with PACS for enterprise-wide storage. The platform has established partnerships with major cardiovascular imaging and AI solution providers, including Merative's Merge Cardio, Fujifilm's LISENDO 880 ultrasound system, Aidoc's aiOS, deepcOS, Ascend Cardiovascular, and TeraRecon's Eureka Clinical AI Platform, allowing for consolidated management of AI interpretation solutions and potential integration with EHRs for a holistic patient view.
What the Web Says
Us2.ai is an AI-driven echocardiography reporting software that automates the analysis of cardiac ultrasounds, aiming to improve efficiency and accuracy in diagnosing heart conditions. It provides fully automated measurements and disease detection, delivering structured reports in seconds. The platform is FDA-cleared and CE marked, integrating with existing hospital infrastructure.
Overall: PositiveStrengths
- Significantly reduces diagnosis and reporting time (by 10-20 minutes or 33% per study).
- Enhances measurement accuracy and consistency, reducing variability between sonographers.
- Aids in early detection of conditions like cardiac amyloidosis through AI-based pattern recognition.
- Zero-click analysis and real-time processing streamline workflow.
- Integrates with various ultrasound devices, PACS, CVIS, and EMR systems.
- Preserves clinical autonomy by allowing sonographers and cardiologists to review and edit AI-generated measurements.
Limitations
- Initial technical challenges with integration into existing systems were reported, though these have since been resolved with updates.
- Some sonographers initially expressed concerns about AI potentially replacing their roles.
- Trust in AI from physicians and sonographers needed to be built through validation and comparison with manual measurements.
- Limited public reviews on platforms like G2, Glassdoor, and Capterra make it difficult to gather a wide range of independent user opinions.
- Reddit discussions primarily focus on the general impact of AI in cardiac sonography rather than specific Us2.ai product reviews.
Based on reviews from: Us2.ai Testimonials, Us2.ai: AI Echocardiography Reporting Software, FDA-Cleared, User Perceptions of AI Echo | Us2.ai, How to Evaluate AI Echocardiography Platforms - Us2.ai, Top 10 Us2.ai Alternatives & Competitors in 2026 - G2, Compare EchoPAC vs. Us2.ai in 2026 - Slashdot, Compare Ultromics vs. Us2.ai in 2026 - Slashdot, AI-driven tools into echocardiography practice : r/cardiacsonography - Reddit, AI proved superior in assessing and diagnosing cardiac function when compared with echocardiogram assessments made by sonographers : r/science - Reddit, AI Echo in Clinical Workflow | Us2.ai, Capterra Pros and Cons | User Likes & Dislikes - G2, Best Artificial Intelligence Software: User Reviews from July 2026 - G2, Working at USAI: Employee Reviews | Indeed.com, G2 AI Reviews (Voice and Chat): We Tested Them, Here's the Verdict - Blastra, Capterra Reviews 2026: Details, Pricing, & Features | G2, Capterra: Find The Right Software, G2: Business Software and Services Reviews, Open Positions - Microsoft Research, MassMutual: A Life Insurance & Financial Services Company, IHG Careers | Hotel Jobs & Hospitality Careers, Glass Onion: A Knives Out Mystery - Wikipedia, Working at Ai2: Employee Reviews | Indeed.com, Top 8 Claude Skills for UI/UX Engineers - Snyk, Real-Time Jobsite Management Software | Fieldwire by Hilti | Fieldwire by Hilti, Gravador de tela gru00e1tis da Bandicam - O Melhor Programa de Captura de Tela, Vu00eddeos e Jogos
Last updated: 2026-07-22
Videos
News, demos, and interviews about Us2.ai.
Videos load interactively. If none appear, search YouTube for Us2.ai →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]